No. 18-899

Saint Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals, Inc., et al.

Lower Court: Federal Circuit
Docketed: 2019-01-11
Status: Denied
Type: Paid
Experienced Counsel
Tags: administrative-law administrative-proceeding federal-circuit indian-tribe inter-partes-review patent-challenge patent-law patent-office patent-trial-and-appeal-board sovereign-immunity tribal-sovereign-immunity
Key Terms:
Patent Privacy JusticiabilityDoctri
Latest Conference: 2019-04-12
Question Presented (AI Summary)

Whether inter partes review before the Patent Trial and Appeal Board is the type of proceeding in which tribal sovereign immunity may be asserted

Question Presented (OCR Extract)

QUESTION PRESENTED This case involves the legal characterization of the inter partes review procedure for patents, created by the Leahy—Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011). This Court has described inter partes review as a “procedure allow[ing] private parties to challenge previously issued patent claims in an adversarial process before the Patent Office that mimics civil litigation.” SAS Inst. Inc. v. Iancu, 138 8. Ct. 1348, 1352 (2018). In this case, the Federal Circuit held that a federally recognized Indian tribe owning a patent could not assert tribal sovereign immunity in an Inter partes review proceeding because the proceeding is “more like an agency enforcement action than a civil suit brought by a private party.” Pet. App. 9a. The Question Presented is: Whether inter partes review before the Patent Trial and Appeal Board is the type of proceeding in which tribal sovereign immunity may be asserted. i

Docket Entries

2019-04-15
Petition DENIED.
2019-03-20
DISTRIBUTED for Conference of 4/12/2019.
2019-03-18
Reply of petitioners Saint Regis Mohawk Tribe and Allergan, Inc. filed.
2019-03-06
Brief of respondents Mylan Pharmaceuticals Inc., et al. in opposition filed.
2019-02-07
Motion to extend the time to file a response is granted and the time is extended to and including March 11, 2019.
2019-02-05
Motion to extend the time to file a response from February 11, 2019 to March 11, 2019, submitted to The Clerk.
2018-12-20
Petition for a writ of certiorari filed. (Response due February 11, 2019)

Attorneys

Mylan Pharmaceuticals Inc.
Charles G. Curtis Jr.Perkins Coie LLP, Respondent
Charles G. Curtis Jr.Perkins Coie LLP, Respondent
Saint Regis Mohawk Tribe and Allergan, Inc.
Jonathan S. MasseyMassey & Gail, LLP, Petitioner
Jonathan S. MasseyMassey & Gail, LLP, Petitioner